Obstructive sleep apnea (OSA), a global public health issue marked by repeated upper airway collapse during sleep, is tied to diverse diseases—from ...
Postmenopausal women are especially vulnerable to hypertension, which is a major cardiovascular risk factor. Women ...
Obstructive sleep apnea (OSA), a global public health issue marked by repeated upper airway collapse during sleep, is tied to diverse diseases-from cardiovascular conditions to cancer.
ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.
LivaNova (Nasdaq: LIVN) today announced its new strategic roadmap and long-range financial plan at its 2025 Investor Day.
Daybreak, a provider of fully at-home sleep apnea diagnosis and treatment, has named Robert Miller, RPSGT, as its new senior vice president of commercial strategy.
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today hosted its 2025 Investor Day and presented ...
Sleep-disordered breathing (SDB), ranging from habitual snoring to severe obstructive sleep apnea (OSA), is highly prevalent ...
Polar changes accelerate global warming and trigger health crises—from new diseases to mental stress—calling for urgent ...
Amy Schumer is starting afresh amid her recent weight loss. “Back on my staircase bullshit again,” the comedian, 44, ...
The benchmark Russell 2000® Growth Index was up 12.19% for the quarter. Trailing the benchmark, the Wasatch Ultra Growth Fund ...